The scope of medical insurance for medical insurance at the end of this year is basically unified

According to the relevant person in charge of the Medical Service Management Department of Xinhua News Agency, on the 23rd, by the end of 2022, all provinces across the country will complete the "digestion" of local supplementary drugs to achieve basically unified scope of medical insurance drugs across the country.

The person in charge introduced that in recent years, my country's medical security industry has developed rapidly, and the national medical insurance catalog has been dynamically adjusted every year. More than 500 drugs in 4 years have been included in the directory. After negotiation, the price of drugs has been greatly reduced. The medicines in China are better replaced, and it is of little significance to retain local supplements.

As of June 30, 2022, 15 provinces and Xinjiang Production and Construction Corps have completed the "digestion" task of supplementary drugs in advance. The completion time of the "digestion" of the remaining 16 provinces was the end of 2022.

According to the person in charge, overall, including Beijing, including Beijing, "digestion" in various provinces across the country, supplementary drugs have lower prices and better quality alternatives in the existing national medical insurance directory, and the impact of the transfer is not great.

Taking the ibuprofen that was transferred from the third batch of "digestive" drugs in Beijing as an example, the "ibuprofen gel" was called out. Capsules, tablets, oral fluids, particles, ointments and other dosage forms can meet the needs of clinical medication.

The basis of the scope of medical insurance drugs is basically unified, which is an important measure to solve the problem of imbalance and inadequate problems in the field of medical security. The person in charge introduced that this will help enhance the fairness of my country's medical security system, the balance and inclusiveness of medical security treatment, and at the same time, by forming a national unified pharmaceutical purchase market, better play the role of medical insurance strategy, enhance the masses of different places Convenience for medical treatment, improve the medical insurance service experience, and improve the well -being of people's livelihood.

- END -